These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 20573249)
1. Total and high molecular weight adiponectin have similar utility for the identification of insulin resistance. Almeda-Valdes P; Cuevas-Ramos D; Mehta R; Gomez-Perez FJ; Cruz-Bautista I; Arellano-Campos O; Navarrete-Lopez M; Aguilar-Salinas CA Cardiovasc Diabetol; 2010 Jun; 9():26. PubMed ID: 20573249 [TBL] [Abstract][Full Text] [Related]
2. High-molecular weight adiponectin/HOMA-IR ratio as a biomarker of metabolic syndrome in urban multiethnic Brazilian subjects. de Abreu VG; Martins CJM; de Oliveira PAC; Francischetti EA PLoS One; 2017; 12(7):e0180947. PubMed ID: 28746378 [TBL] [Abstract][Full Text] [Related]
3. Assessment of the Relationship Between Serum High Molecular Weight Adiponectin Hormone Levels and Insulin Resistance in Patients with Polycystic Ovary Syndrome. Pekcan MK; Tokmak A; Akkaya H; Pekcan G; Onur A; Kısa Ü; Çil AP Horm Metab Res; 2019 Apr; 51(4):261-266. PubMed ID: 31022741 [TBL] [Abstract][Full Text] [Related]
4. Leptin/Adiponectin Ratios Using Either Total Or High-Molecular-Weight Adiponectin as Biomarkers of Systemic Insulin Sensitivity in Normoglycemic Women. Bravo C; Cataldo LR; Galgani J; Parada J; Santos JL J Diabetes Res; 2017; 2017():9031079. PubMed ID: 28626772 [TBL] [Abstract][Full Text] [Related]
5. Dynamics of Nampt/visfatin and high molecular weight adiponectin in response to oral glucose load in obese and lean women. Unlütürk U; Harmanci A; Yildiz BO; Bayraktar M Clin Endocrinol (Oxf); 2010 Apr; 72(4):469-74. PubMed ID: 19650786 [TBL] [Abstract][Full Text] [Related]
6. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Hara K; Horikoshi M; Yamauchi T; Yago H; Miyazaki O; Ebinuma H; Imai Y; Nagai R; Kadowaki T Diabetes Care; 2006 Jun; 29(6):1357-62. PubMed ID: 16732021 [TBL] [Abstract][Full Text] [Related]
7. High molecular weight multimer form of adiponectin as a useful marker to evaluate insulin resistance and metabolic syndrome in Japanese men. Seino Y; Hirose H; Saito I; Itoh H Metabolism; 2007 Nov; 56(11):1493-9. PubMed ID: 17950099 [TBL] [Abstract][Full Text] [Related]
8. Gender differences in serum high-molecular-weight adiponectin levels in metabolic syndrome. Eglit T; Lember M; Ringmets I; Rajasalu T Eur J Endocrinol; 2013 Mar; 168(3):385-91. PubMed ID: 23230211 [TBL] [Abstract][Full Text] [Related]
9. Inverse correlation between serum high-molecular-weight adiponectin and proinsulin level in a Japanese population: The Dynamics of Lifestyle and Neighborhood Community on Health Study. Nakamura A; Miyoshi H; Ukawa S; Nakamura K; Nakagawa T; Terauchi Y; Tamakoshi A; Atsumi T J Diabetes Investig; 2021 Jan; 12(1):63-66. PubMed ID: 32531868 [TBL] [Abstract][Full Text] [Related]
10. The HOMA-Adiponectin (HOMA-AD) Closely Mirrors the HOMA-IR Index in the Screening of Insulin Resistance in the Brazilian Metabolic Syndrome Study (BRAMS). Vilela BS; Vasques AC; Cassani RS; Forti AC; Pareja JC; Tambascia MA; ; Geloneze B PLoS One; 2016; 11(8):e0158751. PubMed ID: 27490249 [TBL] [Abstract][Full Text] [Related]
11. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes. Mojiminiyi OA; Abdella NA; Al Arouj M; Ben Nakhi A Int J Obes (Lond); 2007 Feb; 31(2):213-20. PubMed ID: 16755284 [TBL] [Abstract][Full Text] [Related]
12. Novel adipokines, high molecular weight adiponectin and resistin, are associated with outcomes following lower extremity revascularization with autogenous vein. Owens CD; Kim JM; Hevelone ND; Hamdan A; Raffetto JD; Creager MA; Conte MS J Vasc Surg; 2010 May; 51(5):1152-9. PubMed ID: 20223619 [TBL] [Abstract][Full Text] [Related]
13. The significance of adiponectin as a biomarker in metabolic syndrome and/or coronary artery disease. Stojanović S; Ilić MD; Ilić S; Petrović D; Djukić S Vojnosanit Pregl; 2015 Sep; 72(9):779-84. PubMed ID: 26554109 [TBL] [Abstract][Full Text] [Related]
14. Leptin to adiponectin ratio - A surrogate biomarker for early detection of metabolic disturbances in obesity. Larsen MA; Isaksen VT; Moen OS; Wilsgaard L; Remijn M; Paulssen EJ; Florholmen J; Goll R Nutr Metab Cardiovasc Dis; 2018 Nov; 28(11):1114-1121. PubMed ID: 30145019 [TBL] [Abstract][Full Text] [Related]
15. [Dyslipidemia prevalence and its relationship with insulin resistance in a population of apparently healthy subjects]. Munguía-Miranda C; Sánchez-Barrera RG; Hernández-Saavedra D; Cruz-López M Salud Publica Mex; 2008; 50(5):375-82. PubMed ID: 18852934 [TBL] [Abstract][Full Text] [Related]
16. The ratio of adiponectin to HOMA as an index of metabolic syndrome in obese women. de Luis DA; Aller R; Izaola O; Conde R; Gonzalez Sagrado M Ann Nutr Metab; 2011 Oct; 58(4):301-6. PubMed ID: 21912107 [TBL] [Abstract][Full Text] [Related]
17. CDH13 genotype-dependent association of high-molecular weight adiponectin with all-cause mortality: the J-SHIPP study. Uetani E; Tabara Y; Kawamoto R; Onuma H; Kohara K; Osawa H; Miki T Diabetes Care; 2014 Feb; 37(2):396-401. PubMed ID: 24041676 [TBL] [Abstract][Full Text] [Related]
18. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity. Hung J; McQuillan BM; Thompson PL; Beilby JP Int J Obes (Lond); 2008 May; 32(5):772-9. PubMed ID: 18253163 [TBL] [Abstract][Full Text] [Related]
19. Metabolomics allows the discrimination of the pathophysiological relevance of hyperinsulinism in obese prepubertal children. Martos-Moreno GÁ; Mastrangelo A; Barrios V; García A; Chowen JA; Rupérez FJ; Barbas C; Argente J Int J Obes (Lond); 2017 Oct; 41(10):1473-1480. PubMed ID: 28588306 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic accuracy of triglyceride/glucose and triglyceride/HDL index as predictors for insulin resistance in children with and without obesity. García AG; Urbina Treviño MV; Villalpando Sánchez DC; Aguilar CA Diabetes Metab Syndr; 2019; 13(4):2329-2334. PubMed ID: 31405638 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]